Global Patent Index - EP 1096929 A1

EP 1096929 A1 2001-05-09 - THERAPEUTIC COMPOSITION BASED ON FLAVONOIDS FOR USE IN THE TREATMENT OF TUMOURS WITH CYTOTOXIC AGENTS

Title (en)

THERAPEUTIC COMPOSITION BASED ON FLAVONOIDS FOR USE IN THE TREATMENT OF TUMOURS WITH CYTOTOXIC AGENTS

Title (de)

THERAPEUTISCHE ZUSAMMENSETZUNG AUF ISOFLAVONOIDBASIS ZUR VERWENDUNG BEI DER BEHANDLUNG VON TUMOREN MIT ZYTOTOXISCHEN MITTELN

Title (fr)

COMPOSITION THERAPEUTIQUE A BASE D'ISOFLAVONO DES DESTINEE A ETRE UTILISEE DANS LE TRAITEMENT DES TUMEURS PAR DES AGENTS CYTOTOXIQUES

Publication

EP 1096929 A1 (FR)

Application

EP 99929481 A

Priority

  • FR 9901715 W
  • FR 9809059 A

Abstract (en)

[origin: FR2781154A1] A composition active against the proliferation of clonogenic cells in tumors contains an isoflavonoid or a chromone type analog.

IPC 1-7 (main, further and additional classification)

A61K 31/35

IPC 8 full level (invention and additional information)

C07D 311/30 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 311/32 (2006.01)

CPC (invention and additional information)

A61K 31/352 (2013.01)

Citation (search report)

See references of WO 0003707A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

EPO simple patent family

FR 2781154 A1 20000121; FR 2781154 B1 20010907; AU 4628299 A 20000207; AU 761417 B2 20030605; BR 9912817 A 20010508; CA 2337256 A1 20000127; CN 1139383 C 20040225; CN 1312712 A 20010912; EA 200100141 A1 20010625; EP 1096929 A1 20010509; IL 140580 D0 20020210; JP 2002520357 A 20020709; WO 0003707 A1 20000127

INPADOC legal status


2004-04-28 [18W] APPLICATION WITHDRAWN

- Effective date: 20040308

2003-07-09 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20030522

2001-05-09 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20010102

2001-05-09 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE